Department of Diabetes and Metabolism, Koseiren Tsurumi Hospital, Oita, Japan.
Department of Gastrointestinal Surgery, Koseiren Tsurumi Hospital, Oita, Japan.
J Diabetes Investig. 2020 May;11(3):573-577. doi: 10.1111/jdi.13157. Epub 2019 Nov 1.
We report the identification of a mutation in the solute carrier family 5 member 2 (SLC5A2) gene, which encodes sodium-glucose cotransporter 2, in a family with familial renal glucosuria. The proband was a 26-year-old Japanese man referred to the diabetes division with repeated glucosuria without hyperglycemia. His mother, uncle and grandfather also had a history of glucosuria. A heterozygous missense mutation (c.303T>A:p.N101K) in SLC5A2 was identified in the patient and his mother, but not in 200 chromosomes from 100 healthy and unrelated individuals, or in 3,408 Japanese individuals in the Tohoku Medical Megabank. Furthermore, bioinformatics software predicted that this lesion would be pathogenic. We infer that the mutation led to clinically relevant sodium-glucose cotransporter 2 dysfunction. The patient showed no symptoms of hypoglycemia, but continuous glucose monitoring confirmed asymptomatic hypoglycemia.
我们报告了一个家族性肾性糖尿病例中溶质载体家族 5 成员 2(SLC5A2)基因突变的鉴定,该基因编码钠-葡萄糖共转运蛋白 2。先证者是一名 26 岁的日本男性,因反复出现糖尿但无高血糖而被转诊至糖尿病科。他的母亲、叔叔和祖父也有糖尿病史。在患者及其母亲中发现了 SLC5A2 中的杂合错义突变(c.303T>A:p.N101K),但在 100 名健康无关个体的 200 条染色体中、在东北医疗百万基因组中的 3408 名日本个体中均未发现该突变。此外,生物信息学软件预测该病变可能具有致病性。我们推断该突变导致了临床相关的钠-葡萄糖共转运蛋白 2 功能障碍。该患者无低血糖症状,但连续血糖监测证实存在无症状性低血糖。